NYSE American - Delayed Quote USD
Calidi Biotherapeutics, Inc. (CLDI)
0.4973
+0.0172
+(3.58%)
At close: April 24 at 4:00:00 PM EDT
0.4750
-0.02
(-4.48%)
After hours: April 24 at 6:00:57 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.15 | -0.11 | -0.45 | -0.32 |
| Low Estimate | -0.15 | -0.11 | -0.45 | -0.32 |
| High Estimate | -0.15 | -0.11 | -0.45 | -0.32 |
| Year Ago EPS | -1.98 | -- | -- | -0.45 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 2 | 2 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -2.7 | -1.45 | -0.86 | -0.37 |
| EPS Actual | -1.98 | -1.4 | -0.65 | -0.27 |
| Difference | 0.72 | 0.05 | 0.2 | 0.1 |
| Surprise % | 26.81% | 3.45% | 23.98% | 27.03% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.15 | -0.11 | -0.45 | -0.32 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CLDI | 92.41% | -- | -- | 28.89% |
| S&P 500 | 6.94% | 4.52% | 8.32% | 14.18% |
Upgrades & Downgrades
| Initiated | Ladenburg Thalmann: Buy | 6/27/2024 |
| Maintains | Baird: Outperform to Outperform | 5/15/2024 |
| Maintains | Baird: Outperform to Outperform | 3/21/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/21/2024 |
| Initiated | HC Wainwright & Co.: Buy | 11/22/2023 |
| Initiated | Baird: Outperform | 10/9/2023 |
Related Tickers
ALGS Aligos Therapeutics, Inc.
5.83
+8.77%
RVPH Reviva Pharmaceuticals Holdings, Inc.
0.9000
+4.32%
BIVI BioVie Inc.
0.8941
+6.42%
SGMT Sagimet Biosciences Inc.
3.1200
+12.43%
ACXP Acurx Pharmaceuticals, Inc.
0.4017
+3.80%
RENB Renovaro Inc.
0.3728
-0.75%
CANF Can-Fite BioPharma Ltd.
1.1700
-0.85%
ENLV Enlivex Therapeutics Ltd.
0.9600
+4.35%
SLXNW Silexion Therapeutics Corp
0.0367
-47.42%
ALLR Allarity Therapeutics, Inc.
1.0700
+5.94%